WallStSmart

Ping An Biomedical Co., Ltd. (PASW)vsPDD Holdings Inc. (PDD)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

PDD Holdings Inc. generates 1225579% more annual revenue ($418.54B vs $34.15M). PDD leads profitability with a 24.4% profit margin vs -37.6%. PDD earns a higher WallStSmart Score of 77/100 (B+).

PASW

Avoid

26

out of 100

Grade: F

Growth: 2.7Profit: 2.0Value: 5.0Quality: 5.0

PDD

Strong Buy

77

out of 100

Grade: B+

Growth: 8.0Profit: 8.5Value: 10.0Quality: 8.5
Piotroski: 4/9Altman Z: 3.53
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for PASW.

PDDUndervalued (+67.8%)

Margin of Safety

+67.8%

Fair Value

$332.33

Current Price

$102.61

$229.72 discount

UndervaluedFair: $332.33Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

PASW1 strengths · Avg: 10.0/10
Price/BookValuation
0.5x10/10

Reasonable price relative to book value

PDD6 strengths · Avg: 9.8/10
P/E RatioValuation
9.8x10/10

Attractively priced relative to earnings

Return on EquityProfitability
30.5%10/10

Every $100 of equity generates 31 in profit

Debt/EquityHealth
0.0310/10

Conservative balance sheet, low leverage

Free Cash FlowQuality
$45.66B10/10

Generating 45.7B in free cash flow

Altman Z-ScoreHealth
3.5310/10

Safe zone — low bankruptcy risk

Market CapQuality
$139.25B9/10

Large-cap with strong market position

Areas to Watch

PASW4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$17.51M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-67.4%2/10

ROE of -67.4% — below average capital efficiency

Revenue GrowthGrowth
-62.0%2/10

Revenue declined 62.0%

PDD0 concerns · Avg: 0/10

No major concerns identified

Comparative Analysis Report

WallStSmart Research

Bull Case : PASW

The strongest argument for PASW centers on Price/Book.

Bull Case : PDD

The strongest argument for PDD centers on P/E Ratio, Return on Equity, Debt/Equity. Profitability is solid with margins at 24.4% and operating margin at 23.1%. PEG of 1.03 suggests the stock is reasonably priced for its growth.

Bear Case : PASW

The primary concerns for PASW are EPS Growth, Market Cap, Return on Equity.

Bear Case : PDD

No major red flags identified for PDD, but monitor valuation.

Key Dynamics to Monitor

PASW profiles as a turnaround stock while PDD is a mature play — different risk/reward profiles.

PDD is growing revenue faster at 9.0% — sustainability is the question.

PDD generates stronger free cash flow (45.7B), providing more financial flexibility.

Monitor TEXTILE MANUFACTURING industry trends, competitive dynamics, and regulatory changes.

Bottom Line

PDD scores higher overall (77/100 vs 26/100), backed by strong 24.4% margins. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Ping An Biomedical Co., Ltd.

CONSUMER CYCLICAL · TEXTILE MANUFACTURING · USA

Ping An Biomedical Co., Ltd., provides supply chain management services in the apparel industry in China.

PDD Holdings Inc.

CONSUMER CYCLICAL · INTERNET RETAIL · China

Pinduoduo Inc., operates an electronic commerce platform in the People's Republic of China. The company is headquartered in Shanghai, the People's Republic of China.

Visit Website →

Compare with Other TEXTILE MANUFACTURING Stocks

Want to dig deeper into these stocks?